Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ACET

Adicet Bio (ACET) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $5.61 -2.3% on the day -61.6% over 12 months 52-week range $5.61 – $16.64

Share price and insider trades

ACET closeInsider buyInsider sale
5101520NovDecJan 2026FebMarAprMayJunJulAugSepOctEEarnings release filed 2025-11-05EEarnings release filed 2026-03-12EEarnings release filed 2026-05-13EEarnings release filed 2026-08-05Sold $206,765 on 2026-04-07 · Advisors Israel Ii Ltd OrbimedSold $468,082 on 2026-04-08 · Advisors Israel Ii Ltd OrbimedBought $525,022 on 2026-02-18 · Ra Capital Healthcare Fund LpBought $535,472 on 2026-02-19 · Ra Capital Healthcare Fund LpBought $543,440 on 2026-02-20 · Ra Capital Healthcare Fund Lp
Bought, 12 months$6.6M
Sold, 12 months$675K
Insiders buying2
Insiders selling1

Adicet Bio insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $6.6M and 1 sold $675K of ACET stock on the open market.

ACET insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $5.0M bought (2 trades)$5.0MQ4 2025Q1 2026: $1.6M bought (3 trades)$1.6MQ1 2026Q2 2026: $675K sold (4 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$675K4
Q1 2026$1.6M3—0
Q4 2025$5.0M2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit+$22.7MOn all tracked purchases +343.7%

Summary

Over the past 12 months, 2 Adicet Bio, Inc. insiders reported open-market purchases totaling $6.6M, while 1 insider reported sales totaling $675K. Among insiders with enough purchase history to measure, Ra Capital Healthcare Fund Lp (10% Owner) has the highest Insider Score at 98. 0 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

ACET earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 5, 2026 +16.7% None -13.9%S&P -0.4% +20.9%
May 13, 2026 +0.3% None +5.8%S&P +1.4% -4.3%
Mar 12, 2026 +1.5% Bought $1.6M -3.5%S&P -2.1% -6.2%
Nov 5, 2025 -30.2% Bought $5.0M -1.9%S&P -0.7% -21.1%
Aug 7, 2025 -6.8% None -11.4%S&P +0.7% +15.9%
May 6, 2025 +26.6% None -26.4%S&P -0.4% +54.5%
Mar 6, 2025 -9.8% None -9.0%S&P -1.2% -19.7%
Nov 6, 2024 -12.1% None +1.5%S&P +3.3% -21.1%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Apr 13SEC Ra Capital Healthcare Fund Lp10% Owner Buy 74,7511,182,624 held (+7%) $7.27 $543K -22.8% 98
Apr 13SEC Ra Capital Healthcare Fund Lp10% Owner Buy 74,2681,107,873 held (+7%) $7.21 $535K -22.2% 98
Apr 13SEC Ra Capital Healthcare Fund Lp10% Owner Buy 74,5771,033,605 held (+8%) $7.04 $525K -20.3% 98
Apr 9SEC Advisors Israel Ii Ltd Orbimed10% Owner Sell 40,416 $6.52 $264K -14.0% —
Apr 9SEC Advisors Israel Ii Ltd Orbimed10% Owner Sell 32,523 $6.29 $205K -10.8% —
Apr 9SEC Advisors Israel Ii Ltd Orbimed10% Owner Sell 29,31934,923 held (−46%) $6.53 $191K -14.1% —
Apr 9SEC Advisors Israel Ii Ltd Orbimed10% Owner Sell 2,40032,523 held (−7%) $6.38 $15K -12.1% —
Oct 10SEC Orbimed Advisors Llc10% Owner Buy 3,500,0004,490,254 held (+353%) $1.00 $3.5M +461.0% —
Oct 10SEC Orbimed Advisors Llc10% Owner Buy 1,500,0009,026,359 held (+20%) $1.00 $1.5M +461.0% —

Insiders at Adicet Bio, Inc.

InsiderBoughtSoldLast filingScore
Orbimed Advisors Llc10% Owner $5.0M — Oct 10, 2025 —
Ra Capital Healthcare Fund Lp10% Owner $1.6M — Apr 13, 2026 98
Advisors Israel Ii Ltd Orbimed10% Owner — $675K Apr 9, 2026 —

ACET stock: common questions

Are Adicet Bio, Inc. insiders buying ACET stock?

In the past 12 months, 2 insiders reported open-market purchases of ACET worth $6.6M. The latest was 10% Owner Ra Capital Healthcare Fund Lp bought $543K of ACET at $7.27.

Are Adicet Bio, Inc. insiders selling ACET stock?

1 insiders reported sales worth $675K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ACET's 52-week range?

Over the past year ACET has traded between $5.61 and $16.64. It last closed at $5.61 on Oct 9, 2026.